Effect of transcription peptide inhibitors on HIV-1 replication (Q39549994)

13 September 2017

title

Effect of transcription peptide inhibitors on HIV-1 replication (English)

1 reference

13 September 2017

Kylene Kehn-Hall

5

0 references

Fatah Kashanchi

11

object named as

Fatah Kashanchi

1 reference

13 September 2017

Rachel Van Duyne

1

1 reference

13 September 2017

Jessica Cardenas

2

1 reference

13 September 2017

Rebecca Easley

3

1 reference

13 September 2017

Weilin Wu

4

1 reference

13 September 2017

Zak Klase

6

1 reference

13 September 2017

Susana Mendez

7

1 reference

13 September 2017

Chen Zeng

8

1 reference

13 September 2017

Hao Chen

9

1 reference

13 September 2017

Mohammed Saifuddin

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

2 May 2008

1 reference

13 September 2017

1 reference

13 September 2017

volume

376

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

308-322

1 reference

Antiviral activity of CYC202 in HIV-1-infected cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Inhibition of HIV-1 virus replication using small soluble Tat peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

RNA interference directed to CDK2 inhibits HIV-1 transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Tat gets the "green" light on transcription initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Modulation of HIV-1 replication by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Direct interaction of human TFIID with the HIV-1 transactivator tat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

A mightier mouse with human adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Driving the cell cycle to cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat protein trans-activates transcription in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Chromatin remodeling and modification during HIV-1 Tat-activated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Cell proliferation is not required for productive HIV-1 infection of macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Development of a human adaptive immune system in cord blood cell-transplanted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Evidence for Functional Interaction between the HIV-1 Tat Transactivator and the TATA Box Binding Proteinin Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

HIV-1 infection and pathogenesis in a novel humanized mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

inferred from DOI database lookup

7 January 2021

based on heuristic

In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.036

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.02.036

1 reference

13 September 2017

1 reference